The store will not work correctly when cookies are disabled.
3-Phenyl-5-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102938
PubChem CID: 72792688
Max Phase: Preclinical
Molecular Formula: C20H16N2O
Molecular Weight: 300.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1-c1cnc2[nH]cc(-c3ccccc3)c2c1
Standard InChI: InChI=1S/C20H16N2O/c1-23-19-10-6-5-9-16(19)15-11-17-18(13-22-20(17)21-12-15)14-7-3-2-4-8-14/h2-13H,1H3,(H,21,22)
Standard InChI Key: WLSORYWMNHIFJW-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
39.8409 -9.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8397 -10.3273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5542 -10.7401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5524 -9.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1265 -9.0881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2675 -9.4967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2677 -10.3273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0579 -10.5838 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.5460 -9.9117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0575 -9.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4453 -8.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2702 -8.4878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6583 -7.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2221 -7.0602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3938 -7.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0094 -7.8178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1298 -8.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4164 -7.8505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7013 -8.2630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7041 -9.0919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4182 -9.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4212 -10.3249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.7085 -10.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
21 22 1 0
22 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.36 | Molecular Weight (Monoisotopic): 300.1263 | AlogP: 4.91 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.91 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.83 | CX LogP: 4.36 | CX LogD: 4.36 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.58 | Np Likeness Score: -0.40 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |